It is established that streptozocin (STZ) infiltrates the pancreas and invades insulin synthesizing β-cells that subsequently leads to diabetes mellitus (DM) induction evidenced by hypoinsulinemia and hyperglycemia within a week after its administration in the experimental animal models [29,37]. The gene discussed is INS; the disease is diabetes mellitus.